Next vaccine: EMA reviews Chinese Sinovac active ingredient

0 0
Spread the love
Read Time:41 Second

Next vaccination on the way: the European Medicines Agency (EMA) is starting a rolling review of the vaccine from Chinese developer Sinovac for effectiveness, safety and quality, the agency reports.

The vaccine contains dead SARS CoV-2 virus, which is inactive and cannot cause the disease. The Covid-19 vaccine (Vero Cell) also contains an “adjuvant,” a substance that boosts the immune response to the vaccine.

When a person receives the vaccine, his or her immune system identifies the inactivated virus as foreign and makes antibodies against it. When the vaccinated person later comes into contact with SARS-CoV-2, the immune system recognizes the virus and is ready to defend the body against it.

Based on the evaluation, a decision is made whether to make a formal request for approval.

source: kurier.at/picture: bbc.com

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

This post has already been read 841 times!

Related posts

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Comment